Cutting Through The Confusion On US Biosimilar Interchangeability

Experts Offer Clarity Amid Misunderstandings Over US FDA Designation

 
• By Dave Wallace
  
Question mark cards in a jar
Confusion remains over aspects of the US FDA interchangeability designation • Source: Shutterstock

More from Biosimilars

More from Biosimilars & Generics